Healthcare costs increase after escalating HF symptoms
- PDF / 185,929 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 31 Downloads / 190 Views
PharmacoEconomics & Outcomes News 860, p20 - 22 Aug 2020 Healthcare costs increase after escalating HF symptoms The economic burden in patients with chronic heart failure with reduced ejection fraction (HFrEF) increases after a worsening heart failure event (WHFE) with escalating symptoms, according to findings of a Merck Sharp & Dohmefunded study published in Advances in Therapy. Data from the US IBM MarketScan Commercial and Medicare Supplemental Databases (2015–2018) in 16 464 patients under 65 years of age with a claim for HFrEF in 2016 were used to assess the impact of a WHFE on healthcare costs over a period of 12 months, and during the following year, from a private payer perspective. Overall, a WHFE (escalating sign/symptoms requiring IV diuretic therapy or hospitalisation) occurred in 26.8% of patients with HFrEF. Healthcare resource use (HCRU) was significantly greater after a WHFE than in patients with stable chronic HFrEF, with increased adjusted rates of all-cause hospitalisation (0.16 vs 0.02 per patient per month [PPPM]), outpatient visits (3.54 vs 2.73 PPPM) and emergency department visits (0.25 vs 0.06 PPPM) during the during the 12 months after a WHFE (all p
Data Loading...
